223 related articles for article (PubMed ID: 23989188)
1. An investigative peptide-acyclovir combination to control herpes simplex virus type 1 ocular infection.
Park PJ; Antoine TE; Farooq AV; Valyi-Nagy T; Shukla D
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6373-81. PubMed ID: 23989188
[TBL] [Abstract][Full Text] [Related]
2. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
Shimomura Y
Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
[TBL] [Abstract][Full Text] [Related]
3. Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study.
Rousseau A; Boutolleau D; Titier K; Bourcier T; Chiquet C; Weber M; Colin J; Gueudry J; M'Garrech M; Bodaghi B; Burrel S; Agut H; Deback C; ; Labetoulle M
Antiviral Res; 2017 Oct; 146():205-212. PubMed ID: 28939476
[TBL] [Abstract][Full Text] [Related]
4. Characterization of DNA polymerase-associated acyclovir-resistant herpes simplex virus type 1: mutations, sensitivity to antiviral compounds, neurovirulence, and in-vivo sensitivity to treatment.
Wang LX; Takayama-Ito M; Kinoshita-Yamaguchi H; Kakiuchi S; Suzutani T; Nakamichi K; Lim CK; Kurane I; Saijo M
Jpn J Infect Dis; 2013; 66(5):404-10. PubMed ID: 24047739
[TBL] [Abstract][Full Text] [Related]
5. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
[TBL] [Abstract][Full Text] [Related]
6. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
van Velzen M; van de Vijver DA; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2013 Nov; 208(9):1359-65. PubMed ID: 23901090
[TBL] [Abstract][Full Text] [Related]
7. Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in Mice.
Bhutta MS; Shechter O; Gallo ES; Martin SD; Jones E; Doncel GF; Borenstein R
Viruses; 2021 Jan; 13(1):. PubMed ID: 33435520
[TBL] [Abstract][Full Text] [Related]
8. 6-Thioguanine Inhibits Herpes Simplex Virus 1 Infection of Eyes.
Chen D; Liu Y; Zhang F; You Q; Ma W; Wu J; Wu Z
Microbiol Spectr; 2021 Dec; 9(3):e0064621. PubMed ID: 34730435
[TBL] [Abstract][Full Text] [Related]
9. Antiviral effects of Cacicol
Deback C; Rousseau A; Breckler M; Molet L; Boutolleau D; Burrel S; Roque-Afonso AM; Labetoulle M
Antivir Ther; 2018; 23(8):665-675. PubMed ID: 30028308
[TBL] [Abstract][Full Text] [Related]
10. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.
Duan R; de Vries RD; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2008 Sep; 198(5):659-63. PubMed ID: 18627246
[TBL] [Abstract][Full Text] [Related]
11. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
Bourinbaiar AS; Coleman CF
Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic testing of patient herpes simplex virus type 1 and 2 isolates for acyclovir resistance by a novel method based on real-time cell analysis.
Caliaro O; Barbani MT; Klenja S; Morfin F; Frobert E; Gorgievski M; Steinlin-Schopfer J; Suter-Riniker F
J Clin Virol; 2020 Apr; 125():104303. PubMed ID: 32163870
[TBL] [Abstract][Full Text] [Related]
13. Antiviral Activity of Oridonin Against Herpes Simplex Virus Type 1.
Jiang K; Feng J; Qi X; Ran L; Xie L
Drug Des Devel Ther; 2022; 16():4311-4323. PubMed ID: 36573068
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.
Burrel S; Boutolleau D; Azar G; Doan S; Deback C; Cochereau I; Agut H; Gabison EE
J Clin Virol; 2013 Sep; 58(1):321-4. PubMed ID: 23731845
[TBL] [Abstract][Full Text] [Related]
15. Cucumis melo pectin as potential candidate to control herpes simplex virus infection.
Agostinho KF; Rechenchoski DZ; Faccin-Galhardi LC; de Sousa ALN; Cunha AP; Ricardo NMPS; Linhares REC; Nozawa C
FEMS Microbiol Lett; 2021 Mar; 368(4):. PubMed ID: 33565598
[TBL] [Abstract][Full Text] [Related]
16. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
17. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain.
Saijo M; Suzutani T; De Clercq E; Niikura M; Maeda A; Morikawa S; Kurane I
Antiviral Res; 2002 Dec; 56(3):253-62. PubMed ID: 12406508
[TBL] [Abstract][Full Text] [Related]
18. Amentoflavone Inhibits HSV-1 and ACV-Resistant Strain Infection by Suppressing Viral Early Infection.
Li F; Song X; Su G; Wang Y; Wang Z; Jia J; Qing S; Huang L; Wang Y; Zheng K; Wang Y
Viruses; 2019 May; 11(5):. PubMed ID: 31121928
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a theta-defensin in a Murine model of herpes simplex virus type 1 keratitis.
Brandt CR; Akkarawongsa R; Altmann S; Jose G; Kolb AW; Waring AJ; Lehrer RI
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5118-24. PubMed ID: 17962464
[TBL] [Abstract][Full Text] [Related]
20. Effects of antiviral medications on herpetic epithelial keratitis in mice.
Komoto S; Higaki S; Fukuda M; Shimomura Y
Jpn J Ophthalmol; 2015 May; 59(3):194-200. PubMed ID: 25707352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]